MMRF presents highlights for patients at Myeloma 2016
Daniel Auclair et al.
Changing epigenetic markers in CLL patients on ibrutinib
The use of immuno-oncology in lymphoma
Myeloma 2016: Panel discussion on the new treatment paradigm
Gareth Morgan et al.
Highlights from the 2016 European Multiple Myeloma Academy (EMMA) and overview of EMMA 2017
Jesús San Miguel